The Standard Chemical Company was organized in 1911 to produce and sell radium. It was the first American company to do so. Most of the radium went to Europe, as there was little demand in America.
Roger F. Robison, MD; Good Samaritan Hospital
The Standard Chemical Company was organized in 1911 to produce and sell radium. It was the first American company to do so. Most of the radium went to Europe, as there was little demand in America. Therefore, in 1913, Standard formed a subsidiary, Radium Chemical Company (RCC), for marketing and sales promotion. The RCC published a monthly journal, Radium, during 1913–1925 and supported the establishment of the American Radium Society. They also manufactured sealed radium sources and brachytherapy devices. During World War I (1914–1918), the production of luminous paint for military equipment and timepieces utilized 50% of all of the radium produced by Standard and its competitors. Yearly sales of radioluminescent watches and clocks skyrocketed from 8,500 in 1913 to 4 million in 1920.
Belgium Radium took over the market in 1922–1923. Standard ceased mining operations and was slowly liquidated during 1928–1933. However, the RCC continued with paint production, dial painting, and the manufacturing of sealed sources and devices. The manufacturing site in Queens, NY was shut down in 1981. When it was demolished during 1988–1995, the Environmental Protection Agency found 10,000 radium needles, 120 grams of radium, 189 Ci of radioactive waste, 92 tons and 197 gallons of nonradioactive hazardous waste, and 812 tons of radioactive soil and debris.
Workers at Radium Dial (RD), an RCC subsidiary, utilized the desks in an old school in Ottawa, IL. By 1925, they were painting 1 million dials a year. That year, the lawsuits began against US Radium in NJ, which had noted employee deaths from radium during 1922–1924. RD began secretly testing their employees and fired anyone who was sick. After six deaths, RD liquidated and moved a few blocks away to continue business as Luminous Processes (LP). LP was shut down by the Nuclear Regulatory Commission in 1978 and tried to donate their desks to a local Catholic school.
Proceedings of the 98th Annual Meeting of the American Radium Society - americanradiumsociety.org
Frontline Chemo-Free Regimen Supported in HR+/HER2+ Breast Cancer Therapy
January 1st 2024Combining anastrozole with palbociclib, trastuzumab, and pertuzumab as a frontline therapy for hormone receptor–positive, HER2-positive breast cancer may avoid some of the toxicities associated with chemotherapy, says Amy Tiersten, MD.
Oncology On-The-Go Podcast: ASCO 2023 Recap
June 19th 2023Experts from University of California, Los Angeles Health and Mayo Clinic discuss key data presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in the gynecologic and gastrointestinal cancer spaces and how they may impact patient care.